UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032406
Receipt number R000036643
Scientific Title The effect of hormone therapy on chronic inflammation of endometriosis
Date of disclosure of the study information 2018/04/27
Last modified on 2021/05/02 21:59:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of hormone therapy on chronic inflammation of endometriosis

Acronym

The effect of Dienogest on chronic inflammation of endometriosis

Scientific Title

The effect of hormone therapy on chronic inflammation of endometriosis

Scientific Title:Acronym

The effect of Dienogest on chronic inflammation of endometriosis

Region

Japan


Condition

Condition

endometriosis

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the effect of Dienogest on inflammatory cytokine and immune cells in endometriosis

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

To assess the number of immune cells especially regulatory T cells

Key secondary outcomes

To assess the amount of inflammatory cytokines by ELISA or realtime PCR


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >=

Gender

Female

Key inclusion criteria

Inpatient for hysterectomy
can be informed consent

Key exclusion criteria

intaking hormone therapy except Dienogest
pregnancy women

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Taisuke
Middle name
Last name Mori

Organization

Kyoto Prefectural University of Medicine

Division name

Obstetrics and Gynecology

Zip code

6028566

Address

465, Kajii-cho, Hirokoji, Kawaramachi-dori, Kyoto city, Kyoto, Japan

TEL

075-251-5560

Email

moriman@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name Takuya
Middle name
Last name Sugahara

Organization

Kyoto Prefectural University of Medicine

Division name

Obstetrics and Gynecology

Zip code

6028566

Address

465, Kajii-cho, Hirokoji, Kawaramachi-dori, Kyoto city, Kyoto, Japan

TEL

075-251-5560

Homepage URL


Email

sghr-tky@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefectural University of Medicine

Institute

Department

Personal name



Funding Source

Organization

Mochida pharmaceutical company

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto Prefectural University of Medicine

Address

465, Kajii-cho, Hirokoji, Kawaramachi-dori, Kyoto city, Kyoto, Japan

Tel

075-251-5337

Email

rinri@koto.kpu-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 04 Month 01 Day

Date of IRB

2017 Year 05 Month 31 Day

Anticipated trial start date

2018 Year 04 Month 27 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2018 Year 04 Month 27 Day

Last modified on

2021 Year 05 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036643


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name